Trial: 202007216

EMBER: A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination with Anticancer Therapies for Patients with ER+ Locally Advanced or Metastatic Breast Cancer and Other Select Non-
Breast Cancers



Principal Investigator

Ma, Cynthia

Disease Site

Breast; Corpus Uteri

Learn more about this study at: